
AETERNA ZENTARIS INC
Share · CA0079755017 · AEZS (XTSE)
No Price
n/a
Performance
Jour | Semaine | Mois | 3 mois | 6 mois | 1 an | 5 ans |
---|---|---|---|---|---|---|
- | - | - | - | -3,37 % | -13,29 % | -94,01 % |
Profil de l'entreprise pour AETERNA ZENTARIS INC Action
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and to develop human 3D intestinal tissue models to study infection biology; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd., Novo Nordisk Novo Nordisk Health Care AG, and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the United States and Canada, as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina.
Données de l'entreprise
Nom AETERNA ZENTARIS INC
Société Aeterna Zentaris Inc.
Symbole AEZS
Site web
https://www.zentaris.com
Marché d'origine
TSX
ISIN CA0079755017
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Capitalisation boursière 18 Mio
Pays États-Unis d'Amérique
Devise CAD
Employés 0,0 T
Adresse 315 Sigma Drive, 29486 Summerville
Date d'introduction en bourse 2000-05-10
Changements d'identifiant
Date | De | À |
---|---|---|
01.07.2004 | AELA | AEZS |
Symboles boursiers
Nom | Symbole |
---|---|
NASDAQ | AEZS |
Autres actions
Les investisseurs qui détiennent AETERNA ZENTARIS INC ont également les actions suivantes dans leur portefeuille :
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles.
Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.